Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals-Reference-Cited by-同舟云学术

Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals

Published:2005-07 Issue:1 Volume:26 Page:88-91
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Bongiovanni Marco,Cicconi Paola,Landonio Simona,Meraviglia Paola,Testa Letizia,Di Biagio Antonio,Chiesa Elisabetta,Tordato Federica,Bini Teresa,Monforte Antonella d’Arminio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection;Palella;N Engl J Med,1998

2. Decline in deaths from AIDS due to new antiretrovirals;Hoggs;Lancet,1997

3. Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor;Mocroft;AIDS,1998

4. Insight into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients;d’Arminio Monforte;AIDS,2000

5. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. http://www.aidsinfo.nih.gov/ [accessed 9 March 2005].

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin;Clinical Infectious Diseases;2023-11-20

2. Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis;Viruses;2022-03-03

3. Ongoing Clinical Trials and the Potential Therapeutics for COVID-19 Treatment;COVID-19;2021

4. An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment;Food and Chemical Toxicology;2020-10

5. Drug repurposing approach to fight COVID-19;Pharmacological Reports;2020-09-05